Evaluating the Impact of Baduanjin Exercise Intervention on Quality of Life in Breast Cancer Survivors Receiving Aromatase Inhibitor Therapy

Change from Baseline IL-6 at 3 months

proinflammatory cytokines interleukin-6

Time frame: at baseline and 3 months

Change from Baseline Fatigue at 3 months

Piper fatigue questionnaire

Time frame: at baseline and 3 months

Change from Baseline sleep quality at 3 months

Pittsburgh sleep quality index, PSQI

Time frame: at baseline and 3 months

Change from Baseline Aromatase Inhibitor-Induced Arthralgia at 3 months

Brief Pain Inventory-Short Form

Time frame: at baseline and 3 months

Change from Baseline Symptoms of climacteric syndrome at 3 months

Kupperman Index

Time frame: at baseline and 3 months

Change from Baseline BMD at 3 months

Bone mineral density

Time frame: at baseline and 3 months

Change from Baseline BMI at 3 months

Body Mass Index

Time frame: at baseline and 3 months

Change from Baseline Aerobic Fitness Assessment at 3 months

Six-min walk test (6MWT)

Time frame: at baseline and 3 months

Change from Baseline Muscle strength test at 3 months

Upper strength: hand grip (measured by a dynamometer; the average of 3 readings) lower limb strength：sit-to-stand (measured as number of reps in a 30-s period)

Time frame: at baseline and 3 months

Change from Baseline Flexibility test at 3 months

Test of scratching his back and Sit in the chair and reach

Time frame: at baseline and 3 months

Change from Baseline Balance test at 3 months

stand on one foot

Time frame: at baseline and 3 months

Change from Baseline TNF-α at 3 months

tumor necrosis factor alpha

Time frame: at baseline and 3 months

Change from Baseline IL-1β at 3 months

interleukin-1β

Time frame: at baseline and 3 months

Change from Baseline CRP at 3 months

C-reactive protein

Time frame: at baseline and 3 months